Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1978 4
1979 1
1980 1
1981 1
1982 5
1983 5
1984 7
1985 6
1986 4
1987 5
1988 7
1989 8
1990 5
1991 9
1992 12
1993 5
1994 6
1995 4
1996 3
1997 1
1998 4
1999 3
2000 10
2001 6
2002 4
2003 4
2004 5
2005 6
2006 4
2007 5
2008 8
2009 8
2010 5
2011 3
2012 5
2013 4
2014 6
2015 5
2016 7
2017 8
2018 3
2019 3
2020 3
2021 4
2022 1
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Results by year

Filters applied: . Clear all
Page 1
Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS; TEMPO 3:4 Trial Investigators. Torres VE, et al. Among authors: higashihara e. N Engl J Med. 2012 Dec 20;367(25):2407-18. doi: 10.1056/NEJMoa1205511. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121377 Free PMC article. Clinical Trial.
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, Pirson Y, Schrier RW, Torra R, Torres VE, Watnick T, Wheeler DC; Conference Participants. Chapman AB, et al. Kidney Int. 2015 Jul;88(1):17-27. doi: 10.1038/ki.2015.59. Epub 2015 Mar 18. Kidney Int. 2015. PMID: 25786098 Free PMC article.
[Polycystic kidney disease].
Higashihara E, Nutahara K, Oshi M. Higashihara E, et al. Nihon Rinsho. 1992 Jan;50 Suppl:171-6. Nihon Rinsho. 1992. PMID: 1578673 Japanese. No abstract available.
[Urological cancer].
Kato M, Higashihara E. Kato M, et al. Among authors: higashihara e. Gan To Kagaku Ryoho. 2005 Sep;32(9):1255-9. Gan To Kagaku Ryoho. 2005. PMID: 16184920 Japanese.
[Polycystic kidney disease].
Higashihara E. Higashihara E. Nihon Jinzo Gakkai Shi. 2007;Suppl 50th Ann:83-90. Nihon Jinzo Gakkai Shi. 2007. PMID: 17899832 Review. Japanese. No abstract available.
[Autosomal dominant (adult type) polycystic kidney disease].
Higashihara E, Nutahara K. Higashihara E, et al. Nihon Hinyokika Gakkai Zasshi. 1991 Oct;82(10):1545-60. doi: 10.5980/jpnjurol1989.82.1545. Nihon Hinyokika Gakkai Zasshi. 1991. PMID: 1722832 Free article. Review. Japanese. No abstract available.
[Urolithiasis in hemodialysis patients].
Nutahara K, Higashihara E. Nutahara K, et al. Among authors: higashihara e. Nihon Rinsho. 2004 Jun;62 Suppl 6:370-3. Nihon Rinsho. 2004. PMID: 15250327 Review. Japanese. No abstract available.
Long-Term Outcomes of Longitudinal Efficacy Study With Tolvaptan in ADPKD.
Higashihara E, Nutahara K, Itoh M, Okegawa T, Tambo M, Yamaguchi T, Nakamura Y, Taguchi S, Kaname S, Yokoyama K, Yoshioka T, Fukuhara H. Higashihara E, et al. Kidney Int Rep. 2021 Dec 8;7(2):270-281. doi: 10.1016/j.ekir.2021.11.034. eCollection 2022 Feb. Kidney Int Rep. 2021. PMID: 35155866 Free PMC article.
213 results